01 1Curia
01 1CYCLOSPORINE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-16
Pay. Date : 2013-12-02
DMF Number : 12949
Submission : 1998-04-13
Status : Active
Type : II
20
Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is CYCLOSPORINE, with a corresponding US DMF Number 12949.
Remarkably, this DMF maintains an Active status since its submission on April 13, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2014, and payment made on December 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
